Skip to main content
Clinical Trials/CTRI/2022/09/045922
CTRI/2022/09/045922Not yet recruitingPhase 2

Strategies for rapid acclimatization to high altitude – using different modalities

DEFENCE RESEARCH AND DEVELOPMENTAL ORGANIZATION2 sites in 1 country200 target enrollmentStarted: January 11, 2022Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
200
Locations
2
Primary Endpoint
Incidence of Acute Mountain Sickness

Study Overview

Brief Summary

Exposure at high altitude (HA) induced hypobaric hypoxia is known to deteriorate health and decrease performance. The aim of the study is to develop of Rapid Acclimatization Schedule for HighAltitude in Western sector using different modalities. 400 volunteers within the age range of 20-40 years will be recruited. The volunteers will be randomized into 4 different groups - Control, Drug treated (Acetazolamide), Stay at Moderate Altitude (Short duration) and Intermittent Hypoxia Exposure (IHE). After recording their baseline parameters at Sea Level area they will be inducted to Stage - I HA by air followed by Stage - II HA by road. In all stages differentphysiological, physical and biochemical parameters would be assessed.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 40.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • a) Age group: 20 – 40 years b) Medical history: SHAPE – I.

Exclusion Criteria

  • a) Smokers b) Drinker c) Prior induction to HA d) Medical history of any sort.

Outcomes

Primary Outcomes

Incidence of Acute Mountain Sickness

Time Frame: During the initial days after ascent to high altitude area.

Secondary Outcomes

  • Exercise Capacity at High Altitude(After 48 and 72 hours after reaching high altitude area.)

Investigators

Sponsor
DEFENCE RESEARCH AND DEVELOPMENTAL ORGANIZATION
Sponsor Class
Government funding agency

Study Sites (2)

Loading locations...

Similar Trials